Journal of the National Cancer Institute Advance Access originally published online on September 11, 2007
JNCI Journal of the National Cancer Institute 2007 99(18):1417; doi:10.1093/jnci/djm114
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press.
CORRESPONDENCE |
Re: Atopy and Risk of Non-Hodgkin lymphoma
Affiliations of authors: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia (AEG, CMV); Department of Immunology, Concord Hospital (SR) and School of Public Health (AK, BKA), University of Sydney, New South Wales, Australia; Epidemiology and Genetics Unit, University of York, York, United Kingdom (AMH); Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia (BKA)
Correspondence to: Andrew Edwin Grulich, MBBS, PhD, HIV Epidemiology and Prevention Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2, 376 Victoria St, Darlinghurst NSW 2010, Australia (e-mail: agrulich@nchecr.unsw.edu.au).
| The first 10% of the full text of this article appears below. |
Melbye et al. (1) reported from their case–control study that participants with a history of hay fever or detectable serum antigen-specific immunoglobulin E (IgE) had a reduced risk of non-Hodgkin lymphoma (NHL). Two additional findings, however, led them to conclude that the inverse relationship between atopy and NHL, which was also observed in some
Related Article in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 158-166.